Diabetes decisions — 2025

The appeal for service connection for bilateral hearing loss was dismissed as the benefit sought on appeal had already been granted.

The Board granted effective dates of January 30, 2013, for the award of service connection for tinnitus, bilateral hearing loss, Type II diabetes mellitus, and coronary artery disease with stent.

The Board remands the claims for service connection for type II diabetes mellitus and sleep apnea to correct duty to assist errors.

The Board granted service connection for a heart disability, diabetes mellitus type II, and hypertension due to presumed herbicide exposure. Diabetic peripheral neuropathy of the lower extremities was also granted as secondary to diabetes.

The Veteran withdrew his appeal for service connection of type II diabetes mellitus, and the Board has no further jurisdiction over this issue.

The Board granted effective dates of September 25, 2009, for right knee bony joint enlargement and instability, and September 3, 2014, for other conditions including Graves' disease, avitaminosis, left knee bony joint enlargement, left knee instability, arthritis, diabetes mellitus, type II, hypertension, and depressive disorder.

The Board granted service connection for bilateral hearing loss, tinnitus, and diabetes mellitus, type II. The claims for right hand tremors and a thoracolumbar spine disorder were remanded.

The Board granted service connection for obstructive sleep apnea, diabetes mellitus, type II, and bilateral Charcot feet as secondary to the Veteran's service-connected disabilities.

The Board denied service connection for diabetes mellitus type II, hypertension, and hypothyroidism as the evidence did not support a finding of in-service exposure to herbicide agents or that the disorders were otherwise related to military service.

The Board granted service connection for ischemic heart disease, for accrued benefits purposes, but denied the claim for accrued benefits based on the Veteran's non-service-connected diabetes mellitus type II.

The Board denied an initial evaluation in excess of 30 percent for unspecified depressive disorder with unspecified insomnia disorder, and remanded the issues of entitlement to an initial evaluation in excess of 20 percent for diabetes mellitus type II and an initial compensable evaluation for hypertension.

The Board denied service connection for diabetes mellitus type II, bilateral hearing loss, tinnitus, an eye disability, hypertension, a left knee disability, a right knee disability, and a sinus disability as there was no evidence of a current disability or that any of the conditions were related to the Veteran's active duty service.

The Board granted service connection for hypertension, diabetes mellitus type II (DM II), and coronary artery disease (CAD) due to presumed exposure to herbicide agents during the Veteran's service.

The appeal was dismissed due to the Veteran's passing in November 2024.

The appeal was denied for various issues, including service connection and increased disability ratings.

The Board granted service connection for hypertension, diabetes, and gout, finding that these conditions are caused or aggravated by the Veteran's service-connected sleep apnea.

The Board dismissed the claim for service connection for diabetes mellitus, type II and denied a rating in excess of 70 percent for a mood disorder due to a general medical condition.

The Board denied service connection for a heart disorder, diabetes mellitus, and sleep apnea as the evidence did not support a diagnosis of these conditions during or near to the period on appeal.

The Board granted service connection for thyroid cancer, hypothyroidism to include Hashimoto's disease, and diabetes mellitus type II based on the persuasive evidence of record.

The Board granted service connection for an acquired psychiatric disorder and obstructive sleep apnea, but denied earlier effective dates and higher ratings for hearing loss and tinnitus.